Novogene Europe Adds Single-Cell Sequencing at Cambridge Omics Centre

Novogene Europe, a multiomics research services partner, has expanded its single-cell RNA sequencing capability at its Cambridge Omics Centre, bringing single-cell sequencing workflows built around the 10x Genomics Chromium platform closer to academic, biotech and biopharma researchers in the UK.

The service builds on Novogene Europe’s established single-cell expertise and combines specialist project support, sequencing infrastructure and bioinformatics analysis to help researchers generate deeper biological insight from complex samples and meet growing demand for accessible single-cell transcriptomics.

By profiling gene expression at single-cell or single-nucleus resolution, researchers can explore cellular heterogeneity, identify rare populations and investigate how different cell types and states contribute to biological function.

This announcement follows the launch of Novogene Europe’s Untargeted Metabolomics Service at its Cambridge Omics Centre and marks the next step in a broader phase of capability expansion at the site. It further strengthens the Cambridge Omics Centre as a UK hub for advanced multiomics services and reflects Novogene Europe’s continued investment in local scientific capability and customer support.

Novogene Europe’s Cambridge service initially focuses on 3′ gene expression using cells or nuclei, supported by GEM-X chemistry, high-throughput Illumina sequencing and Novogene Europe’s bioinformatics expertise. The service includes sample processing, quality control, library preparation, sequencing and comprehensive bioinformatics analysis, supporting research across oncology, immunology, neuroscience, stem cell biology, developmental biology and translational research, as well as biomarker and drug discovery.

“Single-cell sequencing is helping researchers study complex biological systems with a level of detail that is difficult to achieve using bulk approaches alone,” said Tingting Zhou, VP of Novogene Europe. “By expanding access to single-cell sequencing workflows through our Cambridge Omics Centre, we are strengthening local support for UK researchers working across areas such as oncology, immunology, neuroscience, developmental biology and translational research.”